Observational study / 2024
One year after a lifestyle intervention, improvements in rheumatoid arthritis and osteoarthritis outcomes were largely sustained.
Following two 16-week randomized trials of the Plants for Joints (PFJ) lifestyle intervention, participants with rheumatoid arthritis (RA) or metabolic syndrome-associated osteoarthritis (MSOA) were followed for 1 year after all received the intervention. Improvements were sustained in the RA group one year post-intervention (mean DAS28 -0.9 points; p<0.001), and WOMAC scores in the MSOA group remained well below baseline (-7.8 points, p<0.001). Sustained improvements were also observed for CRP and waist circumference in both groups, LDL-cholesterol in RA, and weight, HbA1c, and blood pressure in MSOA, alongside net medication decreases.
Shows an association, not proof of cause and effect.
- Study type
- 1-year observational extension of two randomized controlled trials
- Who was studied
- 65 participants with rheumatoid arthritis and 49 with metabolic syndrome-associated osteoarthritis who completed the extension study
- What was measured
- DAS28 (rheumatoid arthritis), WOMAC (osteoarthritis), metabolic outcomes, body composition, medication changes, and adherence
THE PAPER
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial.
Wagenaar CA, Walrabenstein W, van der Leeden M, Turkstra F, Gerritsen M, Twisk JWR, Boers M, van der Esch M, van Middendorp H, Weijs PJM, van Schaardenburg D. RMD Open, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.